Back to Search
LAURA BRUNNER, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1962559849Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
PMID 19643483·Ophthalmology·2009
4-observational
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
PMID 19506065·Antimicrob Agents Chemother·2009
8-other
"Fit-for-purpose" method validation and application of a biomarker (C-terminal telopeptides of type 1 collagen) in denosumab clinical studies.
PMID 19462251·AAPS J·2009
8-other
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
PMID 19393842·Clin Ther·2009
4-observational
Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis.
PMID 19323612·Curr Med Res Opin·2009
3-trial
Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
PMID 18035083·Am Heart J·2007
4-observational
In vitro study of ingested coins: leave them or retrieve them?
PMID 17923204·J Pediatr Surg·2007
8-other
Impact of transgene expression on drug metabolism following systemic adenoviral vector administration.
PMID 16508909·J Gene Med·2006
7-preclinical
The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth.
PMID 16029841·Ann Epidemiol·2005
4-observational
Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450.
PMID 15496614·J Pharmacol Exp Ther·2005
7-preclinical
Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactin.
PMID 15464081·Eur J Pharmacol·2004
4-observational
Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrins.
PMID 15380233·Bioorg Med Chem Lett·2004
4-observational
Metabolic interaction between cyclosporine and sirolimus.
PMID 15239612·Transplantation·2004
7-preclinical
Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses.
PMID 15057884·Stat Med·2004
4-observational
PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum.
PMID 14694122·J Virol·2004
7-preclinical
Effect of sodium alterations on hepatic cytochrome P450 3A2 and 2C11 and renal function in rats.
PMID 12906334·Drug Dev Ind Pharm·2003
7-preclinical
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes.
PMID 12663672·J Biol Chem·2003
8-other
Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels.
PMID 12649386·J Pharmacol Exp Ther·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2601 TVC
NASHVILLE, TN 37232 - Phone
- (615) 322-4916
Quick Facts
- NPI
- 1962559849
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile